Category: Dexamethasone

Posted on | Posted on John Murphy | Leave a Comment on Idiopathic Retroperitoneal Hematoma Associated With Anticoagulation in a Patient With Moderate COVID-19 Pneumonia

Idiopathic Retroperitoneal Hematoma Associated With Anticoagulation in a Patient With Moderate COVID-19 Pneumonia

Hikaru Murooka • Natsumi Yamamoto • Shiho Amano •, et. al. DOI: 10.7759/cureus.87395  Abstract We report a case of idiopathic retroperitoneal hematoma in an 82-year-old man with moderate COVID-19 pneumonia receiving prophylactic anticoagulation therapy. The patient…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Enhanced Treatment in Severe-Critical COVID-19 With Tocilizumab, Remdesivir, Dexamethasone

Enhanced Treatment in Severe-Critical COVID-19 With Tocilizumab, Remdesivir, Dexamethasone

Abdel-Hameed W. Al-Mistarehi • Shadi El-Akawi • Khalid A. Kheirallah,  et. al.DOI: 10.7759/cureus.67467  Abstract Background: Several medications have been proposed to manage COVID-19, with controversial data regarding their clinical benefits. We aimed to investigate the clinical…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on COVID-19: Sleep, Circadian Rhythms and Immunity – Repurposing Drugs and Chronotherapeutics for SARS-CoV-2

COVID-19: Sleep, Circadian Rhythms and Immunity – Repurposing Drugs and Chronotherapeutics for SARS-CoV-2

Allan Giri,Ashokkumar SrinivasanIsaac Kirubakaran Sundar*, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, United States The severe acute…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Timing of Dexamethasone Initiation and Its Impact on the Outcome of COVID-19 Patients

Timing of Dexamethasone Initiation and Its Impact on the Outcome of COVID-19 Patients

Jamila Alonazi • Najla Alrasheed • Saad Aljabr •et. al., DOI: 10.7759/cureus.72983  Abstract Introduction COVID-19 emerged in Wuhan in December 2019 and was declared a pandemic in March 2020. Severe cases manifest with respiratory distress. Corticosteroids,…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on COVID-19 and emerging spinal cord complications: A systematic review

COVID-19 and emerging spinal cord complications: A systematic review

Ritwick Mondal,a Shramana Deb,b Gourav Shome,c Upasana Ganguly,a Durjoy Lahiri,a,d,⁎ and Julián Benito-Leóne,f,g,⁎⁎ Mult Scler Relat Disord. 2021 Jun; 51: 102917.Published online 2021 Mar 21. doi: 10.1016/j.msard.2021.102917 PMCID: PMC7981271 PMID: 33845350 Abstract Background : Spinal cord complications associated with coronavirus infectious disease…[...]

Read More